This new guidance would affect at least 17 million women between the ages of 40 and 49, according to analysis by Avalere Health. The vast majority of these women have health insurance through employer plans, while 1.2 million are covered under the Patient Protection and Affordable Care Act insurance exchanges and 1.1 million by Medicaid expansion, according to the report.
A similar recommendation was issued in 2009. Both received fierce backlash, though some groups, such as the American Cancer Society against Breast Cancer Action, have held fast to the belief that routine breast cancer screenings for women under 50 are unnecessary and do not reduce cancer deaths. In a recent op-ed in the Washington Post, Karuna Jaggar, executive director of Breast Cancer Action, purported the idea biennial mammograms save lives is “founded more on politics and profit than in science.”
More articles on payer issues:
HHS says insurers required to cover all contraceptives: 3 things to know
WellCare posts better-than-expected profit
Insurers now cover most visits to CVS, Walgreens clinics
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
